1. Home
  2. CACI vs HALO Comparison

CACI vs HALO Comparison

Compare CACI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • HALO
  • Stock Information
  • Founded
  • CACI 1962
  • HALO 1998
  • Country
  • CACI United States
  • HALO United States
  • Employees
  • CACI N/A
  • HALO N/A
  • Industry
  • CACI EDP Services
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CACI Technology
  • HALO Health Care
  • Exchange
  • CACI Nasdaq
  • HALO Nasdaq
  • Market Cap
  • CACI 7.3B
  • HALO 7.4B
  • IPO Year
  • CACI 1979
  • HALO N/A
  • Fundamental
  • Price
  • CACI $466.50
  • HALO $47.91
  • Analyst Decision
  • CACI Buy
  • HALO Buy
  • Analyst Count
  • CACI 13
  • HALO 9
  • Target Price
  • CACI $502.83
  • HALO $63.56
  • AVG Volume (30 Days)
  • CACI 376.8K
  • HALO 3.0M
  • Earning Date
  • CACI 04-23-2025
  • HALO 05-06-2025
  • Dividend Yield
  • CACI N/A
  • HALO N/A
  • EPS Growth
  • CACI 22.32
  • HALO 55.40
  • EPS
  • CACI 21.19
  • HALO 3.76
  • Revenue
  • CACI $8,361,975,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • CACI $14.65
  • HALO $24.79
  • Revenue Next Year
  • CACI $7.25
  • HALO $22.65
  • P/E Ratio
  • CACI $22.01
  • HALO $13.36
  • Revenue Growth
  • CACI 14.16
  • HALO 25.64
  • 52 Week Low
  • CACI $318.60
  • HALO $41.28
  • 52 Week High
  • CACI $588.26
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • CACI 66.06
  • HALO 32.31
  • Support Level
  • CACI $459.26
  • HALO $58.38
  • Resistance Level
  • CACI $483.10
  • HALO $69.94
  • Average True Range (ATR)
  • CACI 11.43
  • HALO 3.37
  • MACD
  • CACI -1.24
  • HALO -1.11
  • Stochastic Oscillator
  • CACI 59.49
  • HALO 1.78

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: